INDIA PATENTS
US trade body to investigate alleged Adani solar IPR violations
The US International Trade Commission is investigating Adani Solar USA and Adani Green Energy Ltd India for alleged patent infringement. The complaint, filed by Trina Solar, claims the Adani companies violated patents on solar cells, modules, and panels.
India must build patents, foundation models and skill deeptech talent: GCC executives
More expertise in artificial intelligence and quantum computing is needed from talents for career readiness said a set of panellists at the Bengaluru Tech Summit 2024. ¡°The AI patents filed until the beginning of 2023, 60% came from China, 20% from the US and India¡¯s number is 0.25%. And that is an area of work that Indian GCCs have to really invest and amp up the innovation factor,¡± said Milesh J, vice president, head of strategy & operations at SAP.
Grow Digi gets two patents for sector agnostic blockchain technology layer from govt
Grow Digi, a blockchain technology startup, has developed a technology that improves their application by reducing transaction time, lowering data storage requirements, and enhancing security. "We have been granted two patents from the government's patent office. We are the first Indian firm to have a Layer One patent registered in India," said the founder and managing director, Sachin Kumar.
India secures spot in global top-10 for all 3 major intellectual property rights
India has achieved a top-10 global ranking in patent, trademark, and industrial design filings. The country saw a 6.1% rise in trademark applications in 2023, securing its position as the fourth highest globally. Domestic filers, particularly in sectors like healthcare, agriculture, and apparel, drove this growth. India now boasts the world's second-largest number of active trademark registrations, exceeding 3.2 million.
India¡¯s patent filings double in five years, country now ranks 6th globally
India has experienced significant growth in intellectual property filings, with patents and industrial design filings doubling and trademarks increasing by 60% between 2018 and 2023. This surge has propelled India to 6th globally in patent filings, driven by a rise in resident innovation, according to the commerce and industry ministry.
Health groups raise concerns over patents for rare disease drugs
Health groups and patient advocates are raising concerns over patent monopolies on rare disease drugs in India. They argue that these monopolies, like the one held by Roche for the spinal muscular atrophy drug Risdiplam, restrict access to affordable medication.
Royal Enfield unveils The Flying Flea C6: A new era of electric motorcycles
Royal Enfield unveiled its first electric motorcycle, The Flying Flea C6, under a new brand. Set to launch in spring 2026, the premium-priced motorcycle marks the company's foray into the EV market. Royal Enfield has been investing heavily in EV R&D and infrastructure, with plans for an EV manufacturing plant in Chennai.
Nokia says German court rules in its favour in Amazon patent dispute
In a statement, Nokia's Chief Licensing Officer Arvin Patel said the Munich Regional Court ruled Amazon was using "Nokia's patented video-related technologies in its end-user streaming devices and is selling them illegally without a licence".
Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian market
Lupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The drug, approved for various gastrointestinal conditions, will be marketed as Lupivon in 10 mg and 20 mg strengths. This agreement aims to enhance Lupin's gastroenterology portfolio and address unmet patient needs.
Dispute with Sanofi settled, Panacea scrip soars to over 3-yr high
Panacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involved Panacea's claim that Sanofi's Shan6 vaccine infringed on its EasySix patent. Sanofi agreed not to market the infringing product and withdrew its opposition to Panacea's patent amendment.
Panacea, Sanofi settle patent litigation over hexavalent vaccine
Panacea Biotec has settled a patent infringement case with Sanofi Healthcare India over a hexavalent vaccine. Sanofi will not launch its Shan6 vaccine in India and will withdraw its opposition to Panacea's patent. Panacea will forgo claims for damages. The Delhi High Court disposed of the suit on September 13, 2024.
3 reasons why Indian pharma is getting ready for unstoppable growth
For Indian pharmaceutical companies, this scenario presents a distinct opportunity. Leveraging their established expertise and leadership in global COVID-19 vaccine distribution, along with robust supply chain efficiencies, Indian firms are strategically positioned to capitalize on this market shift. The departure of Chinese players from the market opens a significant gap, which Indian companies are well-equipped to fill .
Patent cliff can turn Indian pharma stocks into investor¡¯s goldmine
Pharma stocks have surged due to a 'Patent Cliff,' where numerous drug patents expire, allowing generic manufacturers, especially in India, to produce cheaper versions. This trend is causing a revenue drop for original drug makers but presents growth opportunities for Indian pharma companies, reflected in the Nifty Pharma index's recent performance.
Ambani calls Jio world's largest mobile data company, India the world's largest data market
Reliance Industries Chairman Mukesh Ambani announced Jio's major impact on global data traffic, carrying nearly 8% of it. He highlighted Jio's affordable services, noting data costs are just 10% of those in developed countries. With 490 million users, Jio is expanding its digital home services across India.
Telcos target 10% share of all global 6G patents in 3 years
India's telecommunications sector set a three-year goal to capture 10% of future global 6G patents. Chaired by Minister Jyotiraditya Scindia, the panel also discussed contributing significantly to global telecom standards, emphasizing the need for better connectivity and quality of services. The initiative includes promoting investments and technology advancements in line with India's requirements.
Indian telcos aim for 10% share in 6G patents in next 3 years
Indian telecom companies aimed for 10% of 6G patents and substantial global standards contributions within three years, aligning research to national needs. This was discussed in a meeting chaired by telecom minister Jyotiraditya Scindia. Industry leaders also highlighted the necessity for a supportive policy framework to achieve full broadband coverage in the country.
AM/NS India launches patented colour coated product in India
India currently consumes around 3.2 million tonne of coated steel each year, he told ET, adding that the demand for this product from the value-added segment is growing at a faster pace than that of steel.
Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement
Mayne Pharma sued India's Sun Pharma for allegedly infringing patents on IMVEXXY, a drug for menopause-related vaginal pain. The lawsuit was filed after Sun Pharma sought FDA approval for a generic version. This action might delay FDA approval for Sun Pharma by 30 months under the Hatch-Waxman Act.
Pharma MNCs seek relief from price control for patented drugs
The Organisation of Pharmaceutical Producers of India (OPPI) is requesting exemptions for patented and orphan drugs from government price controls. They argue that current regulations hinder innovation and want more control over pricing post-patent expiry to provide economic incentives for inventors.
Load More
